Patent · US Active

PGDS as modifiers of the PTEN pathway and methods of use

US8288119B2 · kind B2 · utility

0Cited by

3References

11Claims

0Family size

Assignee

Exelixis, Inc. · US

Inventors

Chunyan Song · Redwood City, US
Michael OLLMANN · San Carlos, US
Lynn Margaret Bjerke · London, GB

Key dates

Filing date	Jun 20, 2005
Grant date	Oct 16, 2012
Priority date	—
Expiry date	Jan 19, 2028

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/12
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Human PGD genes are identified as modulators of the PTEN pathway, and thus are therapeutic targets for disorders associated with defective PTEN function. Methods for identifying modulators of PTEN, comprising screening for agents that modulate the activity of PGD are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.